Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma. (BCX1777-108)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00742495
Recruitment Status : Terminated (Slow Recruitment)
First Posted : August 27, 2008
Last Update Posted : October 24, 2012
Innovative Therapies For Children with Cancer Consortium
Information provided by:
Mundipharma Research Limited

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : September 2010
  Actual Study Completion Date : September 2010